All Updates

All Updates

icon
Filter
Funding
Prolific Machines raises USD 55 million in Series B funding to begin commercialization efforts
Cell-cultured Meat
Jun 6, 2024
This week:
Robinhood launches joint investment accounts
Retail Trading Infrastructure
Yesterday
Partnerships
eToro partners with London Stock Exchange to expand UK stock offerings
Retail Trading Infrastructure
Yesterday
Funding
StorMagic secures funding from Palatine Growth Credit Fund
Edge Computing
Yesterday
Funding
Archera raises USD 17 million in Series B funding for product development and recruitment
Cloud Optimization Tools
Yesterday
Funding
Alto Neuroscience receives grant of USD 11.7 million to support Phase IIb clinical trials of ALTO-100
Precision Medicine
Yesterday
Partnerships
Quest Diagnostics and BD partner to develop flow cytometry-based companion diagnostics for cancer and other diseases
Precision Medicine
Yesterday
Product updates
USPACE Technology Group Limited unveils commercial optical satellites and related aerospace products
Next-gen Satellites
Yesterday
Industry news
Sweden issues study on Gripen fighter jet’s satellite launch capability
Next-gen Satellites
Yesterday
Product updates
Regulation/policy
Terran Orbital receives certification for new manufacturing facility to begin production
Next-gen Satellites
Yesterday
Partnerships
Crisalion Mobility partners with Air Chateau for pre-order of eVTOL aircraft
Passenger eVTOL Aircraft
Yesterday
Cell-cultured Meat

Cell-cultured Meat

Jun 6, 2024

Prolific Machines raises USD 55 million in Series B funding to begin commercialization efforts

Funding

  • Prolific Machines, a biotechnology company specializing in photo molecular biology, has raised USD 54.6 million in series B funding led by The Ki Tua Fund. Breakthrough Energy Ventures, Mayfield, SOSV, Shorewind Capital, Darco Capital, Conti Ventures, and In-Q-Tel (IQT) participated.

  • Prolific Machines will use the funding for commercialization and customer acquisition, marking the company’s transition from proving the efficacy of its process to actively delivering it to people. 

  • Prolific Machines enable the transition from expensive and hard-to-control molecules to a more efficient and sustainable method—light. Through its bioreactors, it offers customers efficient biomanufacturing of high-value bioproducts, including nutritional proteins, antibodies for disease treatment, and cultivated meat.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.